PAH News

May 11, 2020May 11, 2020

At-home System of Inhaled Nitric Oxide Treats PAH Patient Infected With COVID-19

News, PAH News

At-home treatment with inhaled nitric oxide through Genosyl, a tankless delivery system, was used successfully to manage pulmonary arterial hypertension (PAH) complicated by COVID-19 in a patient, according to a ... Read more

May 8, 2020May 8, 2020

EMA Grants Priority Medicines Designation to Sotatercept for PAH

News, PAH News

The European Medicines Agency (EMA) has granted priority medicines (PRIME) designation to investigational therapy sotatercept (ACE-011) for the treatment of patients with pulmonary arterial hypertension (PAH). This designation is ... Read more

May 4, 2020May 4, 2020

PAH Trials Pausing Enrollment for COVID-19, United Therapeutic Says

News, PAH News, PH News

United Therapeutics has temporarily stopped enrolling patients in ongoing clinical trials of treprostinil-based therapies for pulmonary arterial hypertension (PAH) amid the COVID-19 pandemic, the company announced. Treprostinil is a man-made version of the ... Read more

April 27, 2020April 27, 2020

Benefits of Orenitram for PAH Patients Detailed in New Data

News, PAH News

United Therapeutics’ Orenitram (treprostinil) improves heart function and lowers risk status in people with pulmonary arterial hypertension (PAH) who had begun treatment with another approved therapy, new data from a Phase ... Read more

April 23, 2020April 24, 2020

FDA Grants Orphan Drug Designation to Cereno Scientific’s Lead Candidate CS1 for PAH

News, PAH News

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to CS1, Cereno Scientific’s lead therapy candidate for the treatment of pulmonary arterial hypertension (PAH). CS1 is ... Read more

April 22, 2020April 22, 2020

Novel IPAH Mutations Found in Chinese Patients, Study Reports

News, PAH News

Newly identified mutations that contribute to a higher susceptibility of idiopathic pulmonary arterial hypertension (IPAH) in people from China, were found in a pathway commonly targeted by therapies that ... Read more

April 20, 2020April 20, 2020

LENUS Pro Pump for Remodulin May Need Monitoring of Flow Rate

News, PAH News

Tricumed‘s LENUS Pro pump, an implantable device approved in Europe for the long-term intravenous administration of Remodulin (treprostinil) to treat pulmonary arterial hypertension (PAH), does not maintain a steady flow ... Read more

April 15, 2020April 15, 2020

FDA to Review Liquidia’s Application Requesting Approval of LIQ861 for PAH

News, PAH News

The U.S. Food and Drug Administration (FDA) has accepted for review the new drug application (NDA) Liquidia Technologies submitted earlier this year requesting marketing approval of LIQ861, its proprietary inhaled ... Read more

April 13, 2020April 13, 2020

Acceleron’s Sotatercept Granted FDA’s Breakthrough Therapy Status for PAH

News, PAH News

The U.S. Food and Drug Administration (FDA) has granted the designation of breakthrough therapy to Acceleron Pharma‘s investigational molecule sotatercept for the treatment of pulmonary arterial hypertension (PAH). Breakthrough designation is given ... Read more

April 8, 2020April 8, 2020

Sex Hormones Not Found to Play a Role in PAH Development in Single-Center Study

News, PAH News

Despite previous evidence to the contrary, a single-center study suggests that sex hormones do not influence the development or progression of pulmonary arterial hypertension (PAH), nor do they explain ... Read more

Pin It on Pinterest